News

Shares of ImmunityBio (NASDAQ: IBRX) were up 10% at 11:40 a.m. ET on Wednesday. The clinical-stage biotech company focuses on cell therapies and immunotherapy platforms, including vaccines and

Shares of Lumen (NYSE: LUMN) are posting big gains in Wednesday's trading. The telecom's stock was up 16.7% as of 11:30 a.m. ET, according to data from S&P Global Market Intelligence.

Top U.S

Shares of Amarin (NASDAQ: AMRN) were sinking 22.7% as of 10:56 a.m. ET on Wednesday. The steep decline came after the drugmaker announced an organizational restructuring after the market close on

Over the past few years, Biogen (NASDAQ: BIIB) has been engaged in a much-talked-about journey to develop an effective Alzheimer's disease (AD) medicine. On July 6, the company announced that along

The healthcare sector is unlikely to become obsolete anytime soon, but individual companies can very much get left behind if they fail to keep up with the changing dynamics of the industry. That's

Dividend stocks can be worth investing in, even if they don't offer big yields. That's particularly the case when it comes to companies that regularly raise their payouts. Although your initial

Big insurer UnitedHealth (NYSE: UNH) was the very picture of health, at least as far as its stock was concerned on Tuesday. Its price rose by a sprightly 3.3% that day, well eclipsing the 0.7% rise

Novartis (NYSE: NVS) enjoyed a strong rally today, as the Swiss drugmaker announced an improved revenue forecast for 2023 and a massive share repurchase program. Specifically, the drugmaker's stock

Image source: The Motley Fool.

Novartis Ag (NYSE: NVS)Q2 2023 Earnings CallJul 18, 2023, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of Masimo (NASDAQ: MASI) were down by 18.5% as of 1:30 p.m. on Tuesday. The patient monitoring company announced preliminary numbers for the second quarter after the markets closed on Monday

News out of the Peach State has investors feeling peachy about Rivian Automotive (NASDAQ: RIVN) this morning. The electric pickup truck maker received favorable news regarding the development of a

For a dividend-growth investor, the path to lasting success is as simple as buying and holding businesses that are consistently growing. After all, steadily rising profits drive dividend growth over

Employer-sponsored retirement plans like the 401(k) are the primary tool working people use to save for their golden years. People used to spend all or most of their working years with one company

You may have come into close contact with Medtronic (NYSE: MDT) if you've undergone a medical procedure. The company makes devices used in endoscopy, spine surgery, cardiovascular diagnostics -- and

Fool.com contributor Parkev Tatevosian compares Ford (NYSE: F) with AT&T (NYSE: T) to determine the better dividend stock to buy right now.

*Stock prices used were the afternoon prices of July 14

Shares of AT&T (NYSE: T) were falling today after Citigroup downgraded the telecom stock ahead of its earnings report next week.

The stock was down 4.3% as of 11:26 a.m. ET on Monday.

Citi analyst

With shares of Biogen (NASDAQ: BIIB) falling by 11% in the last 30 days, and by 20% in the last five years, could there be an opportunity for enterprising investors to buy the dip on this struggling

When many investors think of tech stocks, they think of high growth potential, particularly in a short amount of time. While that can happen, you don't want to invest with only that thought in mind

Everyone's portfolio should include a couple of monster stocks. What do I mean by "monster"? I'm talking about companies that have a solid earnings track record and offer bright prospects down the

Most Biogen (NASDAQ: BIIB) shareholders are probably excited about the company's newly approved Alzheimer's drug Leqembi right about now, and it's no surprise why. Some commentators are calling for